BIO-TECHNE Corp Unrecognized Tax Benefits that Would Impact Effective Tax Rate
BIO-TECHNE Corp (TECH) had Unrecognized Tax Benefits that Would Impact Effective Tax Rate of $2.80 million as of 2026-06-30, per its 10-K filed 2026-08-24.
Financial Statements › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate · last filed 2026-08-24
- 2026-06-30: Unrecognized Tax Benefits that Would Impact Effective Tax Rate $2.80M.
- 2025-06-30: Unrecognized Tax Benefits that Would Impact Effective Tax Rate $3.30M.
- 2024-06-30: Unrecognized Tax Benefits that Would Impact Effective Tax Rate $5.30M.
- 2023-06-30: Unrecognized Tax Benefits that Would Impact Effective Tax Rate $5.30M.
| Period end | Unrecognized Tax Benefits that Would Impact Effective Tax Rate |
|---|---|
| 2026-06-30 | $2.80M 10-K · filed 2026-08-24 |
| 2025-06-30 | $3.30M 10-K · filed 2025-08-22 |
| 2024-06-30 | $5.30M 10-K · filed 2024-08-22 |
| 2023-06-30 | $5.30M 10-K · filed 2023-08-23 |
| 2022-06-30 | $5.30M 10-K · filed 2022-08-24 |
| 2021-06-30 | $5.20M 10-K · filed 2021-08-25 |
| 2013-06-30 | $1.00K 10-K · filed 2013-08-29 |
| 2012-06-30 | $2.00K 10-K · filed 2013-08-29 |
| 2011-06-30 | $3.00K 10-K · filed 2013-08-29 |
| 2010-06-30 | $5.00K 10-K · filed 2012-08-29 |
| 2009-06-30 | $6.00K 10-K · filed 2011-08-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |